A study to evaluate the effect of repeat oral doses of lamotrigine on cardiac conduction as assessed by 12-lead ECG [electrocardiogram] as compared to placebo and single oral doses of moxifloxacin

Trial Profile

A study to evaluate the effect of repeat oral doses of lamotrigine on cardiac conduction as assessed by 12-lead ECG [electrocardiogram] as compared to placebo and single oral doses of moxifloxacin

Completed
Phase of Trial: Phase I

Latest Information Update: 19 Mar 2007

At a glance

  • Drugs Lamotrigine; Moxifloxacin
  • Indications Bipolar disorders; Epilepsy
  • Focus Adverse reactions
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 19 Mar 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top